Enter any phrase or word you would like to search for and click .
PostNews: Press Release

PHI releases App Suite 2 – more apps and greater applicability
App Suite 2 is the second release in a series of planned App Suite releases, developed to provide automated live-cell studies to researchers worldwide in an unprecedented user-friendly workflow, using PHI’s HoloMonitor-technology.
Learn more …
PostNews: Press Release
Chairman Klas Cramborn has passed away after a period of illness
Learn more …
PostNews: Press Release
PHI expands European distributor network
System-c bioprocess, Aurogene and Labsoft have recently been appointed to respectively represent Phase Holographic Imaging (PHI) in France, Italy and Poland.
Learn more …
PostNews: Interim Report
Interim Report for the third quarter
For the first time, sales during the past 12 months reached 5 MSEK. Since our previous report, much effort has gone into implementing the ambitious market expansion made possible by the capital acquisition this summer.
Learn more …
PostNews: Press Release

Leading life science tools company enters technology assessment agreement with PHI
A major publicly traded life science tools company has entered a technology assessment agreement with Phase Holographic Imaging (PHI). The purpose of the agreement is to assess PHI’s Holo¬Monitor technology for cell biology applications, primarily within immuno-oncology.
Learn more …
PostNews: Press Release

PHI and BioSpherix expand marketing partnership after scientific evaluation
In June 2018, Phase Holographic Imaging (PHI) and BioSpherix Medical entered a collaboration agreement, aiming to co-market the companies’ complementary product lines. BioSpherix develops and market advanced hermetically sealed cell incubators for the control and optimization of cell culture environments.
Learn more …